Diagnostic Value of GSTP1, RASSF1, AND RASSF2 Methylation in Serum of Prostate Cancer Patients

CONCLUSION: Although we observed that the GSTP1 and RASSF1 methylation positivity rates that we examined in our study were higher in patients without prostate cancer, we found that the RASSF2 methylation rate was higher in patients with prostate cancer. randomized controlled studies are needed.PMID:38493315 | DOI:10.22037/uj.v20i.8014

Source: Urology Journal - March 17, 2024 Category: Urology & Nephrology Authors: Emre Aykanli Serdar Arisan Elif Damla Arisan Abdullah Hizir Yavuzsan Source Type: research